Abstract:Abdominal aortic aneurysm (AAA) is a dangerous condition affecting the aorta. Macrophage pyroptosis, phenotypic transformation, and apoptosis of aortic smooth muscle cells (ASMCs) are pivotal mechanisms in AAA pathogenesis. This study explores how Gasdermin B (GSDMB) regulates macrophage non-canonical pyroptosis and its impact on the phenotypic transformation and apoptosis of ASMCs, thereby unveiling the role of GSDMB in AAA pathogenesis. Immunofluorescence analysis was used to assess the expression levels and localization of GSDMB, cysteinyl aspartate-specific protease-4 (Caspase-4), and N-terminal of cleaved GSDMD (N-GSDMD) in AAA tissues. A cell model that mimics macrophage non-canonical pyroptosis was established by treating THP-1 cells with lipopolysaccharide (LPS). THP-1 cells with reduced or increased GSDMB were generated using small interfering RNA (siRNA) or plasmids. Co-culture experiments involving THP-1 cells and HASMCs were conducted to explore the impact of GSDMB on HASMCs. The mitochondrial reactive oxygen species (mtROS) scavenger Mito-TEMPO lowered mtROS levels in THP-1 cells. Our findings revealed that GSDMB was significantly upregulated in AAA macrophages, which was accompanied by robust non-canonical pyroptosis. THP-1 cells showed non-canonical pyroptosis in response to LPS, which was accompanied by an increase in GSDMB. Further research demonstrated that altering GSDMB, either by knockdown or overexpression, can affect macrophage non-canonical pyroptosis as well as the phenotypic transformation and apoptosis of HASMCs. LPS-induced non-canonical pyroptosis in THP-1 cells was associated with an increase in mtROS, whereas Mito-TEMPO effectively decreased non-canonical pyroptosis and the expression of GSDMB. These findings suggest that GSDMB plays a role in AAA macrophage non-canonical pyroptosis, which influences the phenotypic transformation and apoptosis of HASMCs. The mtROS-Dynamin-Related Protein 1 (Drp1) axis is likely to regulate the GSDMB-mediated non-canonical pyroptosis.

Starvation-induced phosphorylation activates gasdermin A to initiate pyroptosis

Gasdermin-mediated Pyroptosis Confers Anticancer Immunity

The metabolite α-KG induces GSDMC-dependent pyroptosis through death receptor 6-activated caspase-8

Pyroptosis: Gasdermin-Mediated Programmed Necrotic Cell Death

Gasdermin D permeabilization of mitochondrial inner and outer membranes accelerates and enhances pyroptosis

Pyroptosis, inflammasome, and gasdermins in tumor immunity

Full-length GSDME mediates pyroptosis independent from cleavage

GSDMB promotes non-canonical pyroptosis by enhancing caspase-4 activity.

Transcription factor Sp1 transcriptionally enhances GSDME expression for pyroptosis

Crosstalk of HDAC4, PP1, and GSDMD in controlling pyroptosis

Protein phosphatase 1 regulates phosphorylation of Gasdermin D and pyroptosis

Inverse regulation of GSDMD and GSDME gene expression during LPS-induced pyroptosis in RAW264.7 macrophage cells

Gasdermin D-mediated pyroptosis: mechanisms, diseases, and inhibitors

Pyroptosis, metabolism, and tumor immune microenvironment

Gasdermin D triggers cardiolipin-driven mitochondrial damage and pyroptosis

E3 Ubiquitin Ligase SYVN1 is a Key Positive Regulator for GSDMD-mediated Pyroptosis

Mannose antagonizes GSDME-mediated pyroptosis through AMPK activated by metabolite GlcNAc-6P

Gasdermin D:The killer protein performs cell pyroptosis

Gasdermin D Affects Aortic Vascular Smooth Muscle Cell Pyroptosis and Ang II-induced Vascular Remodeling

GSDMB involvement in the pathogenesis of abdominal aortic aneurysm through regulation of macrophage non-canonical pyroptosis

Gasdermin D in pyroptosis